A biotechnology platform for non-invasive diagnostics

Impacting global health by improving access to early diagnostic screening tests for infectious diseases

Our technology
Rapid diagnostic testing
We produce early diagnostic screening tools to make a sustainable impact on global health.

Non-invasive

Saliva based test

Anonymous

No trained medical staff required

Affordable

Zero expensive lab equipment

With your help we can change the world
Would you like to know more about our technology and its applications?
PARTNER WITH US
Innovative approach to detecting disease
We use a proprietary DNA based biotechnology to detect biomarkers in saliva without the need for trained medical staff or lab equipment.

Early detection of neglected tropical diseases (NTDs) is the best way to strengthen global health efforts in eradicating deadly diseases. We are partnering with leading health and research organizations to improve the quality of life of people suffering from NTDs. Our team of experienced scientists and business executives are driven by our purpose of making a sustainable impact on global health by innovating diagnostics.

Our team

Huram Konjen

CEO

Entrepreneur with 6 years in leading startups.

Christian Code

CTO

Postdoc researcher with 10 years in biophysics.

Inger Pedersen

Advisor

Former executive from Novo Nordisk.

Leif Larsen

Advisor

Former executive from DK Medicines Agency.

Jiska Reest

Advisor

Harvard researcher & founder of NGO.

Ege Malling

Advisor

Former chief officer from Danske Bank.

Shirin Khalili

Advisor

Former scientific advisor from LEO Pharma.

Jes Trygved

Advisor

Former executive from Lundbeck.

Contact us


Dianox is a biotechnology platform for non-invasive diagnostic testing of infectious diseases in saliva.

Contact us

Ernie Wilkins Vej 17
2450 Copenhagen SV
Denmark
contact@dianox.org